254 related articles for article (PubMed ID: 24037850)
1. Idiotype-specific intravenous immunoglobulin (IVIG) for therapy of autoimmune diseases.
Blank M; Bashi T; Shoenfeld Y
Methods Mol Biol; 2014; 1060():353-61. PubMed ID: 24037850
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model.
Blank M; Anafi L; Zandman-Goddard G; Krause I; Goldman S; Shalev E; Cervera R; Font J; Fridkin M; Thiesen HJ; Shoenfeld Y
Int Immunol; 2007 Jul; 19(7):857-65. PubMed ID: 17576752
[TBL] [Abstract][Full Text] [Related]
3. Novel cross-reactive anti-idiotype antibodies with properties close to the human intravenous immunoglobulin (IVIg).
Macias A; Arce S; Leon J; Mustelier G; Bombino G; Domarco A; Perez R; Lage A
Hybridoma; 1999 Jun; 18(3):263-72. PubMed ID: 10475241
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris.
Mimouni D; Blank M; Payne AS; Anhalt GJ; Avivi C; Barshack I; David M; Shoenfeld Y
Clin Exp Immunol; 2010 Dec; 162(3):543-9. PubMed ID: 20964642
[TBL] [Abstract][Full Text] [Related]
5. Toward molecular targeting with specific intravenous immunoglobulin preparation.
Blank M; Nur I; Toub O; Maor A; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):213-7. PubMed ID: 16391396
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases.
Ruiz de Souza V; Kaveri SV; Kazatchkine MD
Clin Exp Rheumatol; 1993; 11 Suppl 9():S33-6. PubMed ID: 8354005
[TBL] [Abstract][Full Text] [Related]
7. Anti-citrullinated-protein-antibody-specific intravenous immunoglobulin attenuates collagen-induced arthritis in mice.
Svetlicky N; Kivity S; Odeh Q; Shovman O; Gertel S; Amital H; Gendelman O; Volkov A; Barshack I; Bar-Meir E; Blank M; Shoenfeld Y
Clin Exp Immunol; 2015 Dec; 182(3):241-50. PubMed ID: 26132809
[TBL] [Abstract][Full Text] [Related]
8. The advantage of specific intravenous immunoglobulin (sIVIG) on regular IVIG: experience of the last decade.
Svetlicky N; Ortega-Hernandez OD; Mouthon L; Guillevin L; Thiesen HJ; Altman A; Kravitz MS; Blank M; Shoenfeld Y
J Clin Immunol; 2013 Jan; 33 Suppl 1():S27-32. PubMed ID: 23229779
[TBL] [Abstract][Full Text] [Related]
9. Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes.
Schaub A; von Gunten S; Vogel M; Wymann S; Rüegsegger M; Stadler BM; Spycher M; Simon HU; Miescher S
Allergy; 2011 Aug; 66(8):1030-7. PubMed ID: 21385183
[TBL] [Abstract][Full Text] [Related]
10. Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.
Dietrich G; Kazatchkine MD
J Clin Invest; 1990 Mar; 85(3):620-5. PubMed ID: 2312717
[TBL] [Abstract][Full Text] [Related]
11. Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases.
Mouthon L; Kaveri S; Kazatchkine M
Transfus Sci; 1994 Dec; 15(4):393-408. PubMed ID: 10155557
[TBL] [Abstract][Full Text] [Related]
12. Idiotypic modulation of autoimmunity by therapeutic human immunoglobulin preparations (IVIg).
Kaveri SV; Dietrich G; Jobin D; Rossi F; Sultan Y; Lockwood CM; Kazatchkine MD
Adv Nephrol Necker Hosp; 1992; 21():329-46. PubMed ID: 1566650
[No Abstract] [Full Text] [Related]
13. Variable region-connected, dimeric fraction of intravenous immunoglobulin enriched in natural autoantibodies.
Vassilev TL; Bineva IL; Dietrich G; Kaveri SV; Kazatchkine MD
J Autoimmun; 1995 Jun; 8(3):405-13. PubMed ID: 7576001
[TBL] [Abstract][Full Text] [Related]
14. Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses.
Rossi F; Dietrich G; Kazatchkine MD
Immunol Rev; 1989 Aug; 110():135-49. PubMed ID: 2676846
[TBL] [Abstract][Full Text] [Related]
15. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
Hurez V; Kaveri SV; Kazatchkine MD
J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
[TBL] [Abstract][Full Text] [Related]
16. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.
Jordan SC; Toyoda M
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):31-8. PubMed ID: 8033432
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression of EAMG by IVIG is mediated by a disease-specific anti-immunoglobulin fraction.
Fuchs S; Feferman T; Meidler R; Margalit R; Sicsic C; Brenner T; Laub O; Souroujon MC
Ann N Y Acad Sci; 2008; 1132():244-8. PubMed ID: 18567875
[TBL] [Abstract][Full Text] [Related]
18. Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig.
Rossi F; Kazatchkine MD
J Immunol; 1989 Dec; 143(12):4104-9. PubMed ID: 2592768
[TBL] [Abstract][Full Text] [Related]
19. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network.
Dietrich G; Kaveri SV; Kazatchkine MD
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S73-81. PubMed ID: 1728990
[TBL] [Abstract][Full Text] [Related]
20. Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block.
Routsias JG; Kyriakidis NC; Friedman DM; Llanos C; Clancy R; Moutsopoulos HM; Buyon J; Tzioufas AG
Arthritis Rheum; 2011 Sep; 63(9):2783-9. PubMed ID: 21618202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
